A recent article in the Journal of the American Medical Association (JAMA) has again linked use of bisphosphonates for osteoporosis to increased risk of subtrochanteric and femur fractures. The drugs in the bisphosphonate family include Fosamax, Boniva, Actonel,...
Fosamax Osteoporosis Drug
FDA to Outsource Inspections of Non-U.S. Pharmaceutical Factories
With the advent of globalization and the move of manufacturing plants off shore, many drug manufacturers have taken advantage of lower costs and shipped American jobs overseas. Unfortunately the FDA's U.S. based inspectors did not follow overseas to ensure the...
FDA Releases Video about Fosamax Dangers
The FDA released a video updating information regarding atypical femur fractures that have been associated with the use of bisphosphonates to treat osteoporosis. (Fosamax, Actonel, Boniva, Atelvia, Reclast, and their generic equivalents.) Click here to watch the FDA...
Pharmaceutical Companies Perform Clinical Drug Trials in Other Countries
"Prescription drugs kill some 200,000 Americans every year. Will that number go up, now that most clinical trials are conducted overseas...in places where regulation is virtually nonexistent, the F.D.A. doesn’t reach...?" A fascinating article recently discussed the...
Brandi Firm Helps Draw Attention to Dangerous Drugs
For decades, the Brandi Law Firm has represented victims of defective pharmaceutical drugs and medical devices when their use has been shown to be unreasonably dangerous to users. One similarity in all of these cases it that the adverse affects of these drugs was...
Fosamax Osteoporosis Drug Lawsuit
Studies Find Fosamax Increases the Risk for Rare Leg Fracture Fosamax was heavily marketed following its introduction to the consumer market in 1999. Millions of patients were prescribed Fosamax to treat or prevent Osteoporosis, especially in women going through...